MyPath™ for Clinical: Enhanced Digital Clinical Trials has been saved
MyPath™ for Clinical: Enhanced Digital Clinical Trials
A platform that accelerates digital clinical trial execution
Better health outcomes start with stronger connections. ConvergeHEALTH’s MyPath platform effectively connects patients, caregivers, clinicians, investigators, and life sciences organizations to accelerate digital clinical trials, improve clinical trial matching, and drive retention.
- Conducting clinical trials during a pandemic
- Improving engagement among patients
- Why ConvergeHEALTH MyPath for Clinical?
- Watch the video
- The MyPath for Clinical difference
Hearts of Athletes Program advances digital clinical studies
The Hearts of Athletes Program, powered by Deloitte’s ConvergeHEALTH MyPath for Clinical cloud-based digital platform, is embarking on an innovative new study to understand the effects of COVID-19 on athletes’ heart health. The MyPath platform will make it possible for athletes to enroll and participate in the study from any mobile device.
This approach has the potential to allow patients to participate from wherever they are, have a better experience, and helps the physicians, investigators, and others involved in the study collaborate and respond more quickly. It could also give us the tools and a template for future studies.
– Dr. Manesh Patel, chief of cardiology at Duke University School of Medicine
Deloitte’s ConvergeHEALTH MyPath for Clinical platform will help researchers meet their objectives by:
- Increasing patient engagement
- Recruiting a geographically dispersed and diverse pool of
- Enabling faster, more informed analysis
Keep scrolling to learn how our solution, ConvergeHEALTH MyPath for Clinical, can help accelerate digital clinical trials, improve clinical trial matching, and drive retention.
Duke “Hearts of Athletes” study
Powered by MyPath for Clinical
The Hearts of Athletes Program, powered by Deloitte’s ConvergeHEALTH MyPath for Clinical cloud-based digital platform, is embarking on an innovative study to understand the effects of COVID-19 on athletes’ heart health. Learn how the study and the ConvergeHEALTH My Path digital platform are enabling a new, decentralized digital trial approach and paving the way for the future of clinical trials.
Conducting clinical trials during a pandemic
COVID-19 has impacted the industry’s ability to conduct trials with broad travel restrictions, concerns about investigative site capacity, and most importantly patient safety considerations. US and international regulatory bodies have moved quickly to encourage the adoption of remote data capture and telemedicine capabilities with patient and investigator safety as paramount concerns.1
MyPath for Clinical is a cloud-based digital platform designed to accelerate the execution of digital clinical trials. It brings digital engagement, telemedicine via virtual consults, and the ability for remote data collection and compliance monitoring, to allow trial processes to proceed remotely during COVID-19, and help enhance the productivity and patient experience of trials once the pandemic is behind us. MyPath can improve engagement among patients, investigators, and clinical research associates (CRAs) through real-time data access, a convenient and effective user experience, and more digital direct-to-patient data collection and sharing. It can be used globally and tailored across study phases while supporting various therapeutic areas.
Improving engagement among patients, investigators, and clinical research associates
A patient-centric, cloud-based platform, MyPath improves engagement among clinical trial stakeholders. Creating a foundation for digital clinical trials, MyPath enables remote monitoring, real-time patient-reported data collection, and innovative techniques designed to engage patients. This approach makes digital clinical trials more efficient and effective while delivering a better experience for patients and investigators. An improved patient experience can help transform the clinical trial experience and open a path to virtual and pragmatic trials.
MyPath’s modular capabilities are delivered via a single, connected platform that can be used globally and tailored across study phases while supporting various therapeutic areas.
Why ConvergeHEALTH MyPath for Clinical?
Better-supported patients lead to better real-world evidence—and stronger outcomes. That’s why we designed MyPath to facilitate and improve the sharing of information among patients, investigators, and sponsors in a way that transforms the overall clinical experience. MyPath achieves this by:
- Connecting patients, investigators, and sponsors through personalized education and actions, communication, and dashboards that deliver a real-time understanding of the clinical trial process and more data-driven conversations
- Enabling more direct patient data capture in hybrid virtual and digital clinical trial designs, reducing the burden on the patient and eliminating common barriers to clinical trial recruitment and retention
- Creating transparency and access by investigators and sponsors to real-time patient data, providing a simplified path to adherence, compliance, and study data
The MyPath for Clinical difference
MyPath connects life sciences companies to new sources of value with a global digital trial platform focused on driving innovation, engagement, and more efficient digital clinical trials. With a common platform, users benefit from:
Check out other relevant content below
1 Guidance on the management of clinical trials during the COVID-19 (Coronavirus) pandemic, version 3 28/04/2020, European Medicines Agency, Commission européenne/Europese Commissie, https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanceclinicaltrials_covid19_en.pdf